A common variant of CDKN2A (p16) predisposes to breast cancer
Open Access
- 1 October 2005
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 42 (10) , 763-765
- https://doi.org/10.1136/jmg.2005.031476
Abstract
Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio (OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 (p = 0.002) and after age 50 it was 1.3 (p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 (OR = 3.8; p = 0.0002). Conclusions:CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.Keywords
This publication has 24 references indexed in Scilit:
- CDKN2A Common Variants and Their Association with Melanoma Risk: A Population-Based StudyCancer Research, 2005
- Germline mutation and large deletion analysis of theCDKN2A andARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancerInternational Journal of Cancer, 2004
- Inactivation of the cyclin‐dependent kinase inhibitor 2A (CDKN2A) gene in squamous cell carcinoma of the larynxMolecular Carcinogenesis, 2004
- Identification of a splice acceptor site mutation in p16INK4A/p14ARF within a breast cancer, melanoma, neurofibroma prone kindredJournal of Medical Genetics, 2003
- Hereditary p16-Leiden Mutation in a Patient with Multiple Head and Neck TumorsAmerican Journal of Human Genetics, 2003
- An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility AlleleJournal of Investigative Dermatology, 2002
- Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.2002
- Methylation Silencing and Mutations of the p14ARF and p16INK4a Genes in Colon CancerLaboratory Investigation, 2001
- Methylation of the p16Ink4a tumor suppressor gene 5′-CpG island in breast cancerCancer Letters, 2001
- High Frequency of Multiple Melanomas and Breast and Pancreas Carcinomas in CDKN2A Mutation-Positive Melanoma FamiliesJNCI Journal of the National Cancer Institute, 2000